JAK-STAT signaling pathway in non-infectious uveitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

JAK-STAT signaling pathway in non-infectious uveitis

Published:2022-10 Issue: Volume:204 Page:115236
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Su Yuhan,Tao Tianyu,Liu Xiuxing,Su Wenru

Funder

Sun Yat-Sen University Zhongshan Ophthalmic Center State Key Laboratory of Ophthalmology

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference204 articles.

1. Uveitis: Diagnostic work-up;Seve;A literature review and recommendations from an expert committee, Autoimmun Rev,2017

2. Differential expression of suppressor of cytokine signalling proteins in Behcet's disease;Hamedi;Scand. J. Immunol.,2014

3. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China;Yang;Curr. Eye Res.,2005

4. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review;Rosenbaum;Semin. Arthritis Rheum.,2019

5. A Focus on the Epidemiology of Uveitis;Tsirouki;Ocul Immunol Inflamm,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for necrotizing scleritis in rheumatoid arthritis patients;Expert Review of Ophthalmology;2024-07-23

2. Management of JIA associated uveitis;Best Practice & Research Clinical Rheumatology;2024-07

3. Janus Kinase Inhibitors as a Third-Line Therapy for Refractory Endogenous Noninfectious Uveitis;Ocular Immunology and Inflammation;2024-05-06

4. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis;Frontiers in Immunology;2023-10-26

5. In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors;Journal of Biomolecular Structure and Dynamics;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3